Sponsored By
Advanced Instruments
Headline Sponsor
Advanced Instruments is a global provider of scientific and analytical solutions for the biopharma and clinical industries. Our company’s innovations have helped organizations improve quality, achieve reliable outcomes, and increase productivity for more than 70 years. Our focus on service, quality, and reliability has made us a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. Our Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. And our OsmoTECH® and OsmoPRO® micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.
Meet Our Expert Speakers
Cell Culture & Quality Control Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include:
Eric Wallenstein
Senior Director, Global Regulatory Affairs - CMC,
AskBio
Josh Bagley
CSO,
a:head bio AG
Paula Meleady
Associate Professor,
Dublin City University
Pedro Pinto
Lab Head Experimental Urology,
University of Greifswald
Tamara Zietek
Chief Scientific Officer,
Doctors Against Animal Experiments
Imaging Starts Using Brand New Radiotracer from Nuclidium
The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.
GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
GHR’s total investment in C2N has now broken $50 million since 2020.
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.
Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy
SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.
Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma
The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.
Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions
Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.